Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy
ABSTRACTAntibody-cytokine fusions targeted against tumor-associated antigens (TAAs) are promising cancer immunotherapy agents, with many such molecules currently undergoing clinical trials. However, due to the limited number of tumor-specific targets, on-target off-tumor effects can lead to systemic...
Main Authors: | Vedran Vasic, Can Buldun, Manfred Ritz, Steffen Dickopf, Guy J. Georges, Christian Spick, Alessa Peuker, Thomas Meier, Klaus Mayer, Ulrich Brinkmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2245111 |
Similar Items
-
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
by: Steffen Dickopf, et al.
Published: (2020-01-01) -
Immunotherapy in multiple myeloma
by: Yamna Jadoon, et al.
Published: (2021-01-01) -
Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017-04-01) -
Back-to-Germline (B2G) Procedure for Antibody Devolution
by: Anja Schrade, et al.
Published: (2019-08-01) -
Recombinant antibodies for immunotherapy /
by: Little, Melvyn
Published: (2009)